spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)



Fig. 7. Binding of MyoD and MEF2 to the Mef2c skeletal muscle regulatory region. (A) Sequence of the minimal skeletal muscle regulatory region is shown. The MEF2-binding site extends from nucleotides -64 to -56. The E-box includes nucleotides -38 through -33. (B) Schematic representation of the 1.1 kb Mef2c skeletal muscle control region. The region encompassing nucleotides -512 to +41, with respect to the transcriptional start site of Mef2c (see Fig. 1). The specific MEF2 site and E-box nucleotides mutated for the experiments shown in Fig. 8 are indicated beneath the wild-type sequence. {alpha}-32P-labeled oligonucleotides for the (C) MEF2 site and (D) E-box of the Mef2c skeletal muscle regulatory region were used as probes in gel mobility shift assays with the in vitro translated (C) Myc-tagged MEF2C or (D) MyoD and E12 proteins. Gel shift reactions using unprogrammed reticulocyte lysate are included in parallel lanes. A 100-fold excess of unlabeled (C) MEF2 site or (D) E-box oligonucleotides was used as competitor. (C) Anti-Myc and (D) anti-MyoD antibodies were used for supershifts. Labeled arrows indicate the positions of the various protein-DNA complexes.





Right arrow Return to article